Author: Guest Author

Venue: Virtual meeting via Zoom.

Dates: 6th & 7th February 2021

We would like to invite you to a two-day educational programme on the 6th & 7th of February 2021. The Royal College of Physicians ran the first-ever SCE in Diabetes & Endocrinology in May 2009. This course has evolved over the last 11 years, the first one to run was in 2009.
This interactive programme is organized and chaired by Dr. Moulinath Banerjee, who has developed the programme over the last decade. The salient topics of Diabetes & Endocrinology curriculum will be covered. The speakers, who are all Consultants in Diabetes & Endocrinology, are listed separately with this invitation.
The number of attendees is restricted to 40. In previous years, the course has been over-subscribed, hence please register early to avoid disappointment. The course registration will close on 29th January 2021.
If you would like to attend this meeting, please register here.

Novo Nordisk, Sanofi and the 3rd sponsor (TBC) has provided sponsorship to Endocrine Wellbeing Ltd to support the costs associated with running this meeting. This includes payment of speaker and chairperson honoraria as well as administration and IT costs. No sponsor has influenced the content of the agenda topics or speaker presentations. Please do not hesitate to contact us if you have any questions.
Thanking you
The Weekend SCE Revision course team (ask.diabendo@gmail.com)

The Weekend SCE Revision Course- Diabetes & Endocrinology – 2021

Virtual meeting via Zoom

Agenda

Day 1: 6^th February 2021

08.30am Zoom  call opens

8.55 am Introduction: Dr M Banerjee

9.00 – 10.00 Session E1: Pituitary, MEN & miscellaneous endocrinopathies: Dr D Cuthbertson

10.00 – 11.00 Session E2: Adrenal disorders & Pregnancy with Endocrine disorders: Dr B Issa

11.00 – 11.15 Coffee break            

11.15 – 12.15 Session E3: Reproductive endocrinology: Dr J T Krishnamurthy

12.15 – 13.00 Lunch  [Includes 12.15-12.25 and 12.25-12.35 – 2 sessions of interaction with sponsors]

13.00 – 14.00 Session E4: Thyroid disorders (except thyroid cancers): Dr M Kashif

14.00 – 15.00 Session E6: Pituitary disorders: Dr K Kaushal

15.00 – 15.15 Coffee break

15.15 – 16.15 Session E7: Paediatric & Transitional Endocrinology: Dr Helena Gleeson

16.15 – 17.15 Session D1: Diabetes – General: Dr S Rajbhandari

17.15 – 18.15 D3: Diabetes – special circumstances: Dr M Banerjee

Day 2: 7^th February 2020

8.00 am Zoom call opens

8.15 -9.15 Session E5: Thyroid cancers and nodules: Dr A Mukherjee

9.15 – 10.15 Session D3: Diabetes – complications: Dr N Younis

10.15-10.30 Coffee break

10.30 -11.30 Session M1: Electrolyte disorders: Dr S Adam

11.30 – 12.30 Session M2: Calcium & bone metabolism: Dr A Basu

12.30 – 13.15 Lunch break [Includes 12.30-12.40 – 1 session of interaction with sponsors]

13.15 – 14.15 Session M3: Lipid metabolism & cardiovascular risk: Dr H Bharaj

14.15 – 15.15 Session M4: Obesity: Dr A Syed

15.15 – 16.45 Session T1: Mock exam (90 minutes – 60 questions)

16.45 – 17.30 Session T2: Discussion of Mock exam questions: Dr M Banerjee

17.30 Feedback & Conclusion

Specialty Certificate Examination Diabetes & Endocrine Revision Course tutors

Dr Moulinath Banerjee – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust

Dr Safwaan Adam – Consultant Diabetologist/Endocrinologist, The Christie Hospital, Manchester

Dr Ambar Basu – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust

Dr Harnovdeep Singh Bharaj – Consultant Diabetologist/Endocrinologist, Bolton NHS Foundation Trust

Prof Dan Cuthbertson – Consultant Diabetologist/Endocrinologist, Aintree University Hospital

Dr Helena Gleeson– Consultant Endocrinologist, Queen Elizabeth University Hospital – Birmingham

Dr Mohammed Kashif – Consultant Diabetologist/Endocrinologist, Royal Lancaster Infirmary

Dr Kalpana Kaushal– Consultant Diabetologist/Endocrinologist, Royal Preston Hospital, Lancashire Teaching Hospitals

Dr JT Krishnamurthy – Consultant Diabetologist/Endocrinologist, Pennine Acute Hospitals NHS Trust

Dr Annice Mukherjee – Consultant Endocrinologist, Spire Manchester Hospital.

Prof Satyan Rajbhandari – Consultant Diabetologist/Endocrinologist, Lancashire Teaching Hospitals NHS Foundation Trust

Dr Akheel Syed – Consultant Diabetologist/Endocrinologist, Salford Royal Foundation NHS Trust

Dr Naveed Younis – Consultant Diabetologist/Endocrinologist, Manchester University Foundation NHS Trust       

A District General Hospital, COVID and training: a junior doctor’s perspective | Society for Endocrinology

‘Gone were the preparations to attend the Endocrine Update and the Specialty Certificate Exam. Hello, instead, COVID Medical Registrar Rota.’

Venkatram Subramanian, Specialty Trainee (ST5), Diabetes and Endocrinology, Health Education England North West Deanery, reflects on the the year gone

Date: 6th and 7th November 2020

Venue: Virtual Interactive

Organisers: Dr Handrean Soran & Dr Naveed Younis

Course Lead: Dr Handrean Soran (handrean.soran@mft.nhs.uk)

Any enquires please email the course coordinator (ManSce2020@gmail.com)

An example of what the course provides:

• More than 250 new questions will be discussed in 14 sessions covering the whole curriculum.
• Access to another ~120 questions from our pool (mock exams included).
• Focus on clinically relevant areas and popular exam topics.
• Speaker’s predictions on potential areas of interest.
• An overall update in endocrinology and diabetes.

Who should attend?

SpRs in Endocrinology and Diabetes, CMTs who plan a career in Endocrinology and Diabetes, Chemical Pathology and Metabolic Medicine trainees, any other UK based or overseas trainee or HCP who is intending to have a career in Diabetes and Endocrinology and/or planning to take the SCE exam or to improve his/her knowledge in Endocrinology and Diabetes. Primary care physicians/trainees and overseas doctors are welcome. The course provides an extensive review and update of all the Endocrinology and Diabetes curriculum.

To reserve your place:

• Complete the Registration Form.
• Payment £250.00 before 14th October 2020 (£300 after 14th October 2020): payable via below PayPal account. Please make sure you send your payment once you finish the registration to receive the confirmation . NO confirmation will be sent without receiving the payment.
• Cancellation policy: registration fee is not refundable if cancellation after 26th October 2020.
• Only 40 Places are available. First come, first served. Registration will close on 26th October 2020.
• The link to the online interactive programme will be emailed to the delegates one week in advance. The link allows only one person to join. No other people should be present except the delegate.
• Delegates should keep the camera open all the time during the course to allow best interaction. If the camera is closed or other conditions breached the delegate may be blocked.

Obesity is an emerging independent risk factor for susceptibility to and severity of coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Previous viral pandemics have shown that obesity, particularly severe obesity (BMI > 40 kg/m²), is associated with increased risk of hospitalization, critical care admission and fatalities. In this narrative review, we examine emerging evidence of the influence of obesity on COVID‐19, the challenges to clinical management from pulmonary, endocrine and immune dysfunctions in individuals with obesity and identify potential areas for further research. We recommend that people with severe obesity be deemed a vulnerable group for COVID‐19; clinical trials of pharmacotherapeutics, immunotherapies and vaccination should prioritize inclusion of people with obesity.

https://onlinelibrary.wiley.com/doi/full/10.1111/cob.12403

© 2020 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Obesity: A critical risk factor in the COVID‐19 pandemic
"…viral pandemics have shown that obesity, particularly severe obesity (BMI > 40 kg/m2), is associated with increased risk of hospitalization, critical care admission and fatalities."
https://t.co/m8CMELCdrQ pic.twitter.com/aOmdkdYQhL

— aͥkheͣeͫl syed (@AkheelSyed) August 28, 2020

Fox A, Slater C, Ahmed B, Ammori BJ, Senapati S, Akhtar K, Ellison J, Summers LKM, Robinson A, New JP, Soran H, Adam S, Syed AA. Vitamin D status after gastric bypass or sleeve gastrectomy over 4 years of follow-up. Obes Surg 2019 | doi:10.1007/s11695-019-04318-0

Vitamin D levels are low in 4 in 5 people with obesity prior to bariatric surgery. Routine supplementation following bariatric surgery reduces rates of deficiency/insufficiency.

What: D&E Training Day for Specialty Trainees

When: 26 June 2018, 09:00 – 12:30

Where: Mayo Building, Salford Royal NHS Foundation Trust